Skip to main content
. 2016 Jun 8;7(27):42553–42565. doi: 10.18632/oncotarget.9924

Table 1. Clinicopathological features.

n (%)
Sex M 91 (53.8%)
F 78 (46.2%)
Age median (SD) 68 (±10.71)
60> 124 (73.4%)
60< 45 (26.6%)
TNM
T 0 23 (13.6%)
1 20 (11.8%)
2 17 (10.1%)
3 96 (56.8%)
4 4 (2.4%)
NA 9 (5.3%)
N 0 92 (54.4%)
1 68 (40.2%)
NA 9 (5.3%)
M 0 153 (90.5%)
1 6 (3.6%)
NA 10 (5.9%)
Stage non 23 (13.6%)
IA 18 (10.7%)
IB 12 (7.1%)
IIA 36 (21.3%)
IIB 62 (36.7%)
III 3 (1.8%)
IV 6 (3.6%)
NA 9 (5.3%)